EANS-Adhoc: LifeWatch AG to report on - Second Quarter 2011 Results on August
23, 2011
Geschrieben am 09-08-2011 |   
 
 -------------------------------------------------------------------------------- 
  ad-hoc disclosure transmitted by euro adhoc with the aim of a Europe-wide 
  distribution. The issuer is solely responsible for the content of this 
  announcement. 
-------------------------------------------------------------------------------- 
 
quarterly report 
 
09.08.2011 
 
- Press release, Letter to Shareholders and Presentation visuals  
available at 07:00 a.m. CEST (01:00 EDT) - International Conference  
Call / Audio webcast at 10:00 a.m. CEST (04:00 EDT) 
 
Neuhausen am Rheinfall / Switzerland - LifeWatch AG (SIX Swiss  
Exchange: LIFE) will report on its results for the second quarter  
2011 on Tuesday, August 23, 2011. The company will publish the  
results for the second quarter 2011 in an international press  
release, a letter to shareholders and presentation visuals at 07:00  
a.m. CEST. All documents will also be available for download in the  
Investor Relations section of the LifeWatch Website  
www.irlifewatch.com. 
 
International Live Conference Call / Audio web cast at 10:00 a.m.  
CEST 
 
At 10:00 a.m. CEST, LifeWatch will also discuss the results in a  
conference call which will be accompanied by presentation visuals.  
The conference call is also accessible as a webcast in the Investor  
Relations section of the LifeWatch Website www.irlifewatch.com where  
an archived version will remain available for download. 
 
The local dial-in numbers for the conference call are as follows: 
+ 41 (0)91 610 56 00 (Europe) 
+ 44 (0)203 059 58 62 (UK) 
+ 1 (1)866 291 41 66 (USA - Toll-free) 
 
All participants are requested to dial in at least ten minutes prior  
to the call. No PIN is required to access the call. 
 
About LifeWatch AG: LifeWatch AG, headquartered in Neuhausen am  
Rheinfall and listed on SIX Swiss Exchange (LIFE), Switzerland, is  
the leading healthcare technology and solution company, specializing  
in advanced telehealth systems and wireless remote patient monitoring 
services. LifeWatch services cater to individuals, ranging from  
high-risk and chronically ill patients, to consumers of health and  
wellness products. LifeWatch has subsidiaries in the United States,  
the Netherlands, Japan, the United Kingdom, Switzerland and Israel.  
LifeWatch AG is the parent company of LifeWatch Services Inc., a  
leading US-based cardiac monitoring service provider, and  
manufacturer of telecardiology products. LifeWatch is also  
introducing a new program for Home Sleep Testing of Obstructive Sleep 
Apnea (OSA) patients under the brand name NiteWatch. For additional  
information, please visit www.lifewatch.com und  
www.nitewatchservices.com. 
 
Sign-up for customized E-mail alerts and documentation requests is  
available at http://production.investis.com/lifewatch/alert-service/ 
 
This press release includes forward-looking statements. All  
statements other than statements of historical facts contained in  
this press release, including statements regarding future results of  
operations and financial position, business strategy and plans and  
objectives for future operations, are forward-looking statements. The 
words "believe," "may," "will," "estimate," "continue," "anticipate," 
"intend," "expect" and similar expressions are intended to identify  
forward-looking statements. LifeWatch AG has based these  
forward-looking statements largely on current expectations and  
projections about future events and financial trends that it believes 
may affect the financial condition, results of operations, business  
strategy, short term and long term business operations and  
objectives, and financial needs. These forward-looking statements are 
subject to a number of risks, uncertainties and assumptions. In light 
of these risks, uncertainties and assumptions, the forward-looking  
events and circumstances described may not occur and actual results  
could differ materially and adversely from those anticipated or  
implied in the forward-looking statements. All forward-looking  
statements are based only on data available to LifeWatch AG at the  
time of the issue of this press release. LifeWatch AG does not  
undertake any obligation to update any forward-looking statements  
contained in this press release as a result of new information,  
future events or otherwise. 
 
THIS PRESS RELEASE IS NOT BEING ISSUED IN THE UNITED STATES OF  
AMERICA AND SHOULD NOT BE DISTRIBUTED TO UNITED STATES PERSONS OR  
PUBLICATIONS WITH A GENERAL CIRCULATION IN THE UNITED STATES. THIS  
PRESS RELEASE DOES NOT CONSTITUTE AN OFFER OF SECURITIES OF LIFEWATCH 
AG OR ANY OF ITS SUBSIDIARIES FOR SALE IN THE UNITED STATES OR AN  
INVITATION TO SUBSCRIBE FOR OR PURCHASE ANY SECURITIES OF LIFEWATCH  
AG OR ITS SUBSIDIARIES IN THE UNITED STATES. IN ADDITION, THE  
SECURITIES OF LIFEWATCH AG AND ITS SUBSIDIARIES HAVE NOT BEEN  
REGISTERED UNDER THE UNITED STATES SECURITIES LAWS AND MAY NOT BE  
OFFERED, SOLD OR DELIVERED WITHIN THE UNITED STATES OR TO U.S.  
PERSONS ABSENT REGISTRATION UNDER OR AN APPLICABLE EXEMPTION FROM THE 
REGISTRATION REQUIREMENTS OF THE UNITED STATES SECURITIES LAWS.  ANY  
PUBLIC OFFERING OF SECURITIES TO BE MADE IN THE UNITED STATES WILL BE 
MADE BY MEANS OF A PROSPECTUS THAT MAY BE OBTAINED FROM LIFEWATCH AG  
OR ITS SUBSIDIARIES, AS APPLICABLE, AND WILL CONTAIN DETAILED  
INFORMATION ABOUT THE ISSUER AND ITS MANAGEMENT AS WELL AS FINANCIAL  
STATEMENTS OF THE ISSUER. 
 
Further inquiry note: 
For further information please contact: 
Sensus Investor and Public Relations, Zürich: 
Tel +41 43 366 55 11 
Fax +41 43 366 55 12 
Email lifewatch@sensus.ch 
 
end of announcement                               euro adhoc 
-------------------------------------------------------------------------------- 
 
issuer:      LifeWatch AG 
             Rundbuckstrasse 6 
             CH-8212 Neuhausen am Rheinfall 
phone:       +41 52 632 00 50 
FAX:         +41 52 632 00 51 
mail:        users@lifewatch.com 
WWW:         www.lifewatch.com 
sector:      Healthcare Providers 
ISIN:        CH0012815459 
indexes:     SPI, SPIEX 
stockmarkets: Open Market / XETRA: Frankfurt, free trade: Berlin, Main Standard: 
             SIX Swiss Exchange 
language:   English
  Kontaktinformationen: 
   
  Leider liegen uns zu diesem Artikel keine separaten Kontaktinformationen gespeichert vor. 
  Am Ende der Pressemitteilung finden Sie meist die Kontaktdaten des Verfassers.
  
  
  Neu! Bewerten Sie unsere Artikel in der rechten Navigationsleiste und finden 
  Sie außerdem den meist aufgerufenen Artikel in dieser Rubrik. 
   
  Sie suche nach weiteren Pressenachrichten? 
  Mehr zu diesem Thema finden Sie auf folgender Übersichtsseite. Desweiteren finden Sie dort auch Nachrichten aus anderen Genres. 
   
  http://www.bankkaufmann.com/topics.html 
   
  Weitere Informationen erhalten Sie per E-Mail unter der Adresse: info@bankkaufmann.com. 
   
  @-symbol Internet Media UG (haftungsbeschränkt) 
  Schulstr. 18 
  D-91245 Simmelsdorf 
   
  E-Mail: media(at)at-symbol.de
  
  
  346251
  
weitere Artikel: 
- EANS-Adhoc: LifeWatch AG gibt Resultate für das zweite Quartal 2011 am 23.
August 2011 bekannt -------------------------------------------------------------------------------- 
  Ad-hoc-Mitteilung übermittelt durch euro adhoc mit dem Ziel einer 
  europaweiten Verbreitung. Für den Inhalt ist der Emittent verantwortlich. 
-------------------------------------------------------------------------------- 
 
Quartalsbericht 
 
09.08.2011 
 
- Pressemitteilung, Aktionärsbrief und Präsentationsfolien um 07.00  
Uhr MESZ - Internationale Telefonkonferenz / Audio Webcast um 10.00  
Uhr MESZ 
 
Neuhausen am Rheinfall / Schweiz - LifeWatch AG (SIX mehr...
 
  
- Heidelberger Druckmaschinen AG: Geschäftsjahr 2011/12: Heidelberg veröffentlicht Zahlen für das erste Quartal - operatives Ergebnis verbessert Heidelberg (ots) -  
   - Auftragseingang mit 665 Mio. Euro im Rahmen der Erwartungen 
   - Umsatz mit 544 Mio. Euro währungsbereinigt auf Vorjahresniveau 
   - Auftragsbestand auf 718 Mio. Euro angestiegen 
   - Ergebnis der betrieblichen Tätigkeit verbessert sich auf minus  
     25 Mio. Euro (Vorjahr: minus 35 Mio. Euro) 
   - Nettofinanzverschuldung mit 260 Mio. Euro im Vergleich zum  
     Vorjahr deutlich reduziert 
   - Ausblick 2011/12: Weiterhin ausgeglichenes Vorsteuerergebnis  
     angestrebt - Auswirkung der Schuldenkrise auf Weltwirtschaft mehr...
 
  
- EANS-News: SYGNIS Pharma AG / SYGNIS schließt Patientenrekrutierung der AXIS
2-Studie erfolgreich ab -------------------------------------------------------------------------------- 
  Corporate News übermittelt durch euro adhoc. Für den Inhalt ist der 
  Emittent/Meldungsgeber verantwortlich. 
-------------------------------------------------------------------------------- 
 
Forschung/Entwicklung 
 
Heidelberg (euro adhoc) - SYGNIS schließt Patientenrekrutierung der  
AXIS 2-Studie erfolgreich ab 
 
• 328 Patienten in ca. 80 Schlaganfallzentren und acht Ländern eingebunden 
    • AX200 ist einer der weltweit am weitesten entwickelten 
      mehr...
 
  
- EANS-News: SYGNIS Pharma AG / SYGNIS successfully completes patient recruitment
for AXIS 2 Study -------------------------------------------------------------------------------- 
  Corporate news transmitted by euro adhoc. The issuer/originator is solely 
  responsible for the content of this announcement. 
-------------------------------------------------------------------------------- 
 
Research & Development 
 
Heidelberg (euro adhoc) - SYGNIS successfully completes patient  
recruitment for AXIS 2 Study 
 
• 328 patients recruited at about 80 stroke centres in eight European 
      countries 
    • AX200 is one of the most advanced drug mehr...
 
  
- EANS-News: ANDRITZ-GRUPPE: Erfreuliche Geschäftsentwicklung im 2. Quartal 2011 -------------------------------------------------------------------------------- 
  Corporate News übermittelt durch euro adhoc. Für den Inhalt ist der 
  Emittent/Meldungsgeber verantwortlich. 
-------------------------------------------------------------------------------- 
 
6-Monatsbericht 
 
Graz (euro adhoc) - Graz, 9. August 2011.  Der internationale  
Technologiekonzern ANDRITZ verzeichnete im 2. Quartal 2011 eine  
erfreuliche Geschäftsentwicklung und konnte alle relevanten  
Kennzahlen im Jahresvergleich steigern. 
 
- Der Umsatz der mehr...
 
  
  |   
 |   
 | 
Mehr zu dem Thema Finanzen
 Der meistgelesene Artikel zu dem Thema:
  
Century Casinos wurde in Russell 2000 Index aufgenommen
 
durchschnittliche Punktzahl: 0 Stimmen: 0
 
  
 |